190 related articles for article (PubMed ID: 24626200)
1. CRABP1 provides high malignancy of transformed mesenchymal cells and contributes to the pathogenesis of mesenchymal and neuroendocrine tumors.
Kainov Y; Favorskaya I; Delektorskaya V; Chemeris G; Komelkov A; Zhuravskaya A; Trukhanova L; Zueva E; Tavitian B; Dyakova N; Zborovskaya I; Tchevkina E
Cell Cycle; 2014; 13(10):1530-9. PubMed ID: 24626200
[TBL] [Abstract][Full Text] [Related]
2. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.
Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM
Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of cellular retinoic acid binding protein 1 fosters epithelial-mesenchymal transition in thyroid cancer.
Hsu YC; Huang WC; Kuo CY; Li YS; Cheng SP
Mol Carcinog; 2023 Dec; 62(12):1935-1946. PubMed ID: 37642311
[TBL] [Abstract][Full Text] [Related]
4. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
[TBL] [Abstract][Full Text] [Related]
5. All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1/2 phosphorylation.
Persaud SD; Park SW; Ishigami-Yuasa M; Koyano-Nakagawa N; Kagechika H; Wei LN
Sci Rep; 2016 Mar; 6():22396. PubMed ID: 26935534
[TBL] [Abstract][Full Text] [Related]
6. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
7. Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer.
Sakata K; Kanda M; Shimizu D; Nakamura S; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35417033
[TBL] [Abstract][Full Text] [Related]
8. All-
Nagpal I; Wei LN
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344789
[TBL] [Abstract][Full Text] [Related]
9. Targeting Cellular Retinoic Acid Binding Protein 1 with Retinoic Acid-like Compounds to Mitigate Motor Neuron Degeneration.
Nhieu J; Milbauer L; Lerdall T; Najjar F; Wei CW; Ishida R; Ma Y; Kagechika H; Wei LN
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902410
[TBL] [Abstract][Full Text] [Related]
10. Sonic Hedgehog-Gli1 Signaling and Cellular Retinoic Acid Binding Protein 1 Gene Regulation in Motor Neuron Differentiation and Diseases.
Lin YL; Lin YW; Nhieu J; Zhang X; Wei LN
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32527063
[TBL] [Abstract][Full Text] [Related]
11. EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.
Saller J; Seydafkan S; Shahid M; Gadara M; Cives M; Eschrich SA; Boulware D; Strosberg JR; Aejaz N; Coppola D
Cancer Genomics Proteomics; 2019; 16(5):309-318. PubMed ID: 31467225
[TBL] [Abstract][Full Text] [Related]
12. A new regulatory mechanism for Raf kinase activation, retinoic acid-bound Crabp1.
Park SW; Nhieu J; Persaud SD; Miller MC; Xia Y; Lin YW; Lin YL; Kagechika H; Mayo KH; Wei LN
Sci Rep; 2019 Jul; 9(1):10929. PubMed ID: 31358819
[TBL] [Abstract][Full Text] [Related]
13. CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases.
Nhieu J; Lin YL; Wei LN
Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406141
[TBL] [Abstract][Full Text] [Related]
14. Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites.
Kimura H; Ohtsuka T; Fujimoto T; Date K; Matsunaga T; Cases AI; Abe A; Mizuuchi Y; Miyasaka Y; Ito T; Oda Y; Nakamura M; Tanaka M
Pancreas; 2016 Aug; 45(7):947-52. PubMed ID: 26684862
[TBL] [Abstract][Full Text] [Related]
15. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
16. Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors.
Cases AI; Ohtsuka T; Fujino M; Ideno N; Kozono S; Zhao M; Ohuchida K; Aishima S; Nomura M; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Jan; 43(1):1-6. PubMed ID: 24326362
[TBL] [Abstract][Full Text] [Related]
17. UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors.
Finnerty BM; Moore MD; Verma A; Aronova A; Huang S; Edwards DP; Chen Z; Seandel M; Scognamiglio T; Du YN; Elemento O; Zarnegar R; Min IM; Fahey TJ
Endocr Relat Cancer; 2019 Apr; 26(4):411-423. PubMed ID: 30689542
[TBL] [Abstract][Full Text] [Related]
18. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin.
Lopes JM; Nesland JM; Reis-Filho JS; Holm R
Histopathology; 2002 May; 40(5):464-71. PubMed ID: 12010367
[TBL] [Abstract][Full Text] [Related]
19. Regulation of exosome secretion by cellular retinoic acid binding protein 1 contributes to systemic anti-inflammation.
Lin YW; Nhieu J; Wei CW; Lin YL; Kagechika H; Wei LN
Cell Commun Signal; 2021 Jun; 19(1):69. PubMed ID: 34193153
[TBL] [Abstract][Full Text] [Related]
20. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
